Expand SKYE Menu
SKYE MENU

SKYE Stock Posts


Upcoming Earnings

SKYE Skye Bioscience1.54+0.01 (+0.7%)

Skye Bioscience will report earnings after the market closes. View Calendar The market is expecting a ±15.3% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.5%. View Expected Move (Conf Call: Nov 10 4:30 PM)
Unusual Option Volume

SKYE Skye Bioscience2.15-2.60 (-54.7%)

Skye Bioscience trades 2,262 contracts. The company has the following event: Conference Call and Webcast to Discuss CBeyond Phase 2a Topline Data on Oct 6, 2025. News: Skye Bioscience Reports Topline CBeyond Phase 2a Data from Nimacimab Monotherapy and Combination Clinical Trial
View Details...
SKYE #SkyeBioscience stock declines -62.9% in premarket,

Premarket Decliner

SKYE Skye Bioscience4.75+0.26+5.8%

Premarket:1.76-2.99 (-63.0%)

Skye Bioscience Reports Topline CBeyond Phase 2a Data from Nimacimab Monotherapy and Combination Clinical Trial

Globe NewswireMon, 6-Oct 7:00 AM
Unusual Option Volume

SKYE Skye Bioscience4.05+0.45 (+12.5%)

Skye Bioscience trades 2,283 contracts.
View Details...
Unusual Option Volume

SKYE Skye Bioscience4.30+0.05 (+1.2%)

Skye Bioscience trades 3,407 contracts. The highest volume is in the 19-Dec-25 7.5 calls, which is 74.4% above the current price.
View Details...
Upcoming Earnings

SKYE Skye Bioscience3.86-0.03 (-0.8%)

Skye Bioscience will report earnings after the market closes. View Calendar The market is expecting a ±15.4% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.7%. View Expected Move (Conf Call: Aug 7 4:30 PM)
Load Earlier Posts
Market Data Delayed 15 Minutes